DALLAS, April 22, 2021 /PRNewswire/ -- MicroTransponder Inc., today announced that the pivotal clinical trial results for the Company's investigational Vivistim® Paired Vagus Nerve Stimulation (VNS) System have been published in The Lancet. Each year in the US, 50-60% of the 658,000...
from PR Newswire: https://ift.tt/3vdMoUM
No comments:
Post a Comment